Why is Remedium Life falling/rising?

As of 07-Jul, Remedium Lifecare Ltd's stock price is currently at 1.11, reflecting an increase of 0.02 or 1.83%. The stock has been on a positive trajectory, gaining for the last nine consecutive days and achieving a remarkable 32.14% return during this period. However, despite this recent uptick, the company has faced significant challenges, including a high Debt to EBITDA ratio of -1.00 times and negative results reported over the last three consecutive quarters. The stock has also underperformed in the long term, with a staggering decline of -92.41% over the past year, indicating serious underlying issues despite the recent short-term gains. In the broader market context, Remedium Lifecare's recent performance contrasts sharply with the Sensex, which has seen a slight decline of -0.20% over the past week. While the stock has outperformed its sector by 1.38% today, its long-term performance remains concerning, with negative growth in net sales and profits. The stock's liquidity is adequate for trading, but the falling investor participation, as evidenced by a 46.32% drop in delivery volume, raises questions about sustained interest in the stock. Overall, while the recent price increase may suggest a temporary rebound, the fundamental challenges facing the company indicate a precarious situation moving forward.